New Delhi: Regardless of a long time of coverage initiatives, focused schemes, and non-public sector help, India’s most cancers burden has surged unabated now second solely to China and the US rising relentlessly in each absolute numbers and relative scale, outpacing developments in different fast-growing economies.
Current knowledge from 43 nationwide most cancers registries define an incidence approaching 1.5 million instances and over 0.8 million deaths rating second globally alongside an growing focus in areas with restricted assets.
In the meantime, past statistics, the illness’s toll lands a devastating blow on sufferers’ lives. Households confront extended struggling, financial fragility, and systemic inequities.
Whereas fashionable modalities have made vital strides in turning tumours at numerous phases more and more treatable, creating the required ecosystem—anchored in sturdy infrastructure, expert medical experience, and rigorous protocols, secured inside an equitable financing framework—stays a long-standing problem in India for translating international scientific progress into tangible enhancements in affected person survival and high quality of life.
Confronting this concern, on the inaugural version of the India Oncology Management Summit, ETHealthWorld is ready to carry collectively the nation’s main clinicians, policymakers, and prime innovators to chart a future roadmap for tackling these challenges and making new medical breakthroughs extra accessible to sufferers throughout India, aligned with the nation’s healthcare wants.
The occasion is supported by Servier India as Gold Companion; Affiliate Companion AstraZeneca; and Supporting Companions ImmunoACT Mango Care Basis, Pfizer, Mr Med (Eazymed Applied sciences Pvt. Ltd.), M | O | C Cancer Care and Analysis Centre, Strand Life Sciences and exhibit associate Clinexel Lifesciences.
Setting the tone for the occasion, Vikas Dandekar, Editor – Well being & Pharma, The Financial Occasions, will ship the welcome handle.
The session will then transfer to an exploration of “Tobacco and Cancer in India: Why Prevention Stays Our Greatest Failure—and Our Best Alternative,” by means of a keynote handle by Dr. Pankaj Chaturvedi, Director, ACTREC, Tata Memorial Centre.
Constructing on the keynote, the agenda will discover “The Proper Strategy in Cancer Care: From Breakthroughs to Affect.”
The skilled panel will function Dr. Sameer Bakhshi, Professor & Head, Dept. of Medical Oncology, AIIMS Delhi; Dr. Vinod Raina, Chairman–Oncology, Fortis Memorial Analysis Institute; Dr. Sewanti Limaye, Director – Medical & Precision Oncology and Oncology Analysis, Reliance Basis Hospital; Dr. Jyoti Bajpai, Lead – Medical and Precision Oncology, Apollo Cancer Facilities; and will likely be moderated by Vikas Dandekar, Editor – Well being & Pharma, The Financial Occasions.
The inaugural panel dialogue will likely be adopted by a Particular Visitor Handle by Dr. Manju Sengar, Prof. & Head Medical oncology, specializing in “Doing the Proper Factor in Cancer Care: Lowering Disparities.”
Following the particular handle, Aurélien Breton, Managing Director, Servier India, will share his insights on “Uncommon Cancers in India: Why Precision Medication Issues Extra Than Ever.”
After the associate presentation, Vandana Gupta, Founder, V Care Basis, will carry a survivor’s perspective to the dialog in a session titled “Cancer Care By the Survivor’s Lens.”
The agenda will progress to an in depth examination of “The Cancer Genome Atlas (TCGA): Unlocking the Genetic Code of Cancer.”
The panelists for the session will embody Dr. Shantanu Chowdhury, Professor, CSIR–Institute of Genomics and Integrative Biology (IGIB); Dr. Sanjeeva Srivastava, Professor, IIT Bombay, Founder – Proteomica Worldwide Pvt. Ltd.; Dr. Chintamani, Professor and Chairperson, Surgical Oncology, Sir Ganga Ram Hospital; Dr. Muzammil Shaikh, Principal Director – Medical Oncology, Nanavati Max Institute of Cancer Care; and will likely be moderated by Prathiba Raju, Senior Assistant Editor, ETHealthworld, The Financial Occasions Group.
Following the panel dialogue, Dr. Ramesh Hariharan, Director & CEO, Strand Life Sciences, will make a associate presentation on “Non-Invasive Multi-Cancer Early Detection.”
The business presentation will likely be adopted by a dialogue on “Cancer Facilities: How Efficient Are They in Addressing India’s Rising Cancer Burden?”
The consultants for the session will embody Dr. Kumar Prabhash, Professor & HOD, Medical Oncology, Tata Memorial Hospital; Dr. Dinesh Pendharkar, Director, Sarvodaya Cancer Institute; Dr. Sharat Damodar, Chairman of Oncology Companies & Scientific Director, Mazumdar Shaw Medical Centre, Narayana Well being Metropolis; Dr. Ashish Bakshi, Guide Medical Oncologist, Hemato-oncologist and BMT Doctor, Jupiter Hospital & Bethany Hospital; Dr. Vashishth Maniar, Director, Co-founder & Senior Medical Oncologist, M | O | C Cancer Care and Analysis Centre; and will likely be moderated by Prathiba Raju, Senior Assistant Editor, ETHealthworld, The Financial Occasions Group.
The panel dialogue will likely be adopted by an business presentation titled “The Want for Tremendous-Speciality Pharmacies: Classes from International Oncology Care” by Devashish Singh, Co-founder & CEO, Mr Med (Eazymed Applied sciences Pvt. Ltd.).
Following the business presentation, Dr. Hemant Malhotra, President, Indian Society of Oncology, Professor & Head, Dept. of Medical Oncology, MGM Medical School Hospital, will ship a particular handle.
The particular handle will likely be adopted by a panel dialogue exploring “From Innovation to Access: Reimagining Cancer Care.”
The panelists for the session embody Dr. Daksha Shah, Govt Well being Officer, Public Well being Division, BMC; Dr. Sabita Jiwnani, Professor, Thoracic Surgical procedure, Division of Surgical Oncology, Tata Memorial Hospital; Dr. Ratna Devi, Director, Affected person Academy for Innovation and Analysis, Dakshayani and Amaravati Well being and Training; Gaurav Tripathi, Govt Vice President, Aditya Birla Well being Insurance coverage; and will likely be moderated by Vikas Dandekar, Editor – Well being & Pharma, The Financial Occasions.
Constructing on the price considerations, the summit will additional discover “Cracking the Cancer Code with Reducing-Edge Diagnostics,” an important pillar in bettering affected person outcomes whereas lowering remedy prices.
The session will function Dr. Pratik Chandrani, Assistant Professor, ACTREC, Tata Memorial Centre; Dr. Tanveer Abdul Majeed, Guide Surgical Oncologist (Gastrointestinal, Thoracic & Hepatopancreaticobiliary Companies), Kokilaben Hospital and Lilavati Hospital; Dr. Mandeep Singh Malhotra, Director – Surgical Oncology & Molecular Oncology, CK Birla Hospital; Dr. Dharmishta Basu, Medical Oncologist, Jupiter Hospital; Dr. Kunal Jobanputra, Medical Oncologist & Hemato-oncologist, Guide – Saifee, Jaslok, and SL Raheja Hospitals; and will likely be moderated by Dr. Ajay Phadke, Director of Strategic Enterprise Improvement, Agilus Diagnostics.
The inaugural summit will conclude with closing remarks by Vikas Dandekar, Editor – Well being & Pharma, The Financial Occasions Group.
Source link
#Confronting #Indias #Cancer #Crisis #Medical #Advances #Missing #Access
